Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Minoxidil lowers blood pressure and causes hair growth, with some side effects.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Stopping S100A3 activity slows down hair growth in mice.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Minoxidil controls blood pressure but may cause kidney damage and needs diuretics to prevent swelling.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Keeping the head elevated for 1.5 days after hair transplant surgery helps prevent facial swelling.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.